DnB Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
DnB Asset Management's JAZZ Position: Q3 2026 in Review
DnB Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2026 at 2,927 shares worth $678K. The position accounts for ﹤0.01% of the portfolio, ranked #690.
DnB Asset Management first reported a position in JAZZ in Q1 2026 and has held it in 3 quarters since. The position peaked at $705K in Q2 2026. 670 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- DnB Asset Management held 2,927 shares of Jazz Pharmaceuticals worth $678K as of Q3 2026.
- DnB Asset Management left its Jazz Pharmaceuticals share count unchanged in Q3 2026.
- Jazz Pharmaceuticals made up ﹤0.01% of DnB Asset Management's portfolio in Q3 2026, its #690 holding.
- DnB Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- DnB Asset Management's Jazz Pharmaceuticals position peaked at $705K in Q2 2026.
- 670 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on DnB Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.